SRC and malignant hypertension: Similar patterns were observed when comparing patients with SSc-SRC+ to those with HUS (22.8 [19.5–29.6] pg/ml) and those with MHT (25.5 [17.2–39.3] pg/ml), in which PlGF levels were significantly lower (P < 0.001).